Is Aarey Drugs & Pharmaceuticals Ltd (AAREYDRUGS) a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Aarey Drugs & Pharmaceuticals Ltd is a below average quality company .

Is Aarey Drugs & Pharmaceuticals Ltd (AAREYDRUGS) undervalued or overvalued?

The key valuation ratios of Aarey Drugs & Pharmaceuticals Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone .

What is Aarey Drugs & Pharmaceuticals Ltd (AAREYDRUGS) share price return in the past 10 years?

Aarey Drugs & Pharmaceuticals Ltd share price has appreciated 11.6% annually (CAGR) over the past ten years.

Is Aarey Drugs & Pharmaceuticals Ltd (AAREYDRUGS) a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Strong which suggest that the price of Aarey Drugs & Pharmaceuticals Ltd is likely to Rise in the short term. However, please check the rating on Quality and Valuation before investing

What is the share price of Aarey Drugs & Pharmaceuticals Ltd (AAREYDRUGS)?

Company share prices are keep on changing according to the market conditions. The current trading price of Aarey Drugs & Pharmaceuticals Ltd (AAREYDRUGS) on 17-Apr-2026 16:59:59 at 16:59 is 82.15.

What is the P/E ratio of Aarey Drugs & Pharmaceuticals?

The latest standalone P/E ratio of Aarey Drugs & Pharmaceuticals as of 17-Apr-2026 is 67.79.

What is the P/B ratio of Aarey Drugs & Pharmaceuticals Ltd (AAREYDRUGS)?

The latest standalone P/B ratio of Aarey Drugs & Pharmaceuticals Ltd (AAREYDRUGS) as of 17-Apr-2026 is 1.60.

What is the 52-week high and low of Aarey Drugs & Pharmaceuticals Ltd (AAREYDRUGS)?

The 52-week high of Aarey Drugs & Pharmaceuticals Ltd (AAREYDRUGS) is Rs. 100.00 and the 52-week low is Rs. 49.01.

Aarey Drugs & Pharmaceuticals Ltd (AAREYDRUGS) Share Analysis – Quality, Valuation Zone & Price Trend & DeciZen Rating

Name: Aarey Drugs & Pharmaceuticals Ltd (AAREYDRUGS)
Brand: Aarey Drugs & Pharmaceuticals

Aarey Drugs & Pharmaceuticals Ltd (AAREYDRUGS) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

BSE: 524412 NSE: AAREYDRUGS | Trading | Small Cap

Aarey Drugs & Pharmaceuticals Ltd (AAREYDRUGS)

BSE: 524412 NSE: AAREYDRUGS

Key Metrics

Market Cap

₹233 Cr.

P/E Ratio

67.79

Price to Book (P/B)

1.60

Price to Sales (P/S)

0.60

EV/EBITDA

21.79

Return on Capital Employed (ROCE)

6.38%

Current Price

₹82.2

Return on Equity (ROE)

3.02%

Return on Assets (ROA)

1.36%

Operating Profit Margin

0.6%

Net Profit Margin

0.85%

Gross Profit Margin

1.7%

Book Value per Share

₹51.3

Sales Growth (YoY)

19.19%

Sales Growth (3 Years)

-1.29%

Operating Profit Growth (1 Year)

-55.25%

Operating Profit Growth (3 Years)

-36.64%

Net Profit Growth (1 Year)

-14.1%

52-Week Low / High

₹49 / 100

Net Profit Growth (3 Years)

-15.01%

Dividend Yield

0.00%

Promoter Holding

39.06%

Pledged shares (%)
of Promoter's holding (%)

0.00%

Check Before You Invest

Q.1 Revenue growth of Aarey Drugs & Pharmaceuticals Ltd?

Aarey Drugs & Pharmaceuticals Ltd revenue growth is 19.2% for FY-2025 , which is above its 5 year CAGR of 9.6% , indicating faster growth.

Q.1 Promoter shareholding and pledge status of Aarey Drugs & Pharmaceuticals Ltd?

Promoters hold 39.06% of the Aarey Drugs & Pharmaceuticals Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Revenue growth of Aarey Drugs & Pharmaceuticals Ltd vs industry peers?

Aarey Drugs & Pharmaceuticals Ltd revenue CAGR is 9.57% , compared to the industry median CAGR of 0% , indicating faster growth and gaining its market share.

Q.1 Which industry/sub-sector does Aarey Drugs & Pharmaceuticals Ltd belong to?

Aarey Drugs & Pharmaceuticals Ltd belongs to the Miscellaneous sector, operating specifically within the Trading segment.

Q.1 Stock return of Aarey Drugs & Pharmaceuticals Ltd over the last decade?

Over the last 9 year(s), the stock has delivered a CAGR of 11.7% based on the current price.

DeciZen - make an informed investing decision on Aarey Drugs & Pharma

Based on:

Data

Overall Rating ⓘ
Login to view analysis. M-Cap below 500cr. High Risk from low Liquidity

1. Quality

2. Valuation

3. Price Trend

Aarey Drugs & Pharmaceuticals stock performance

Key Ratios

Is Aarey Drugs & Pharmaceuticals Ltd an attractive stock to invest in?

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	7.2%	22.2%	14.1%	12.1%	8.5%	9.5%	9.9%	6.3%	6.1%	6.4%	-
Value Creation Index ⓘ	-0.5	0.6	0.0	-0.1	-0.4	-0.3	-0.3	-0.6	-0.6	-0.5	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	246	396	349	355	300	348	493	419	398	474	391
Sales YoY Gr.	-	60.9%	-12%	1.7%	-15.4%	16.1%	41.4%	-15%	-5.1%	19.2%	-
Adj EPS ⓘ	0.8	3	2.6	2.8	2.5	2.8	2.6	1.6	1.7	1.4	1.2
YoY Gr.	-	297.4%	-15.6%	9.4%	-11.1%	12.1%	-7.6%	-37.4%	3.7%	-16.2%	-
BVPS (₹) ⓘ	21.8	26.6	33.3	36	38.5	41.3	43.9	45.3	46.5	47.8	51.3
Adj Net Profit ⓘ	1.3	5.5	6	6.5	5.8	6.5	6.5	4.1	4.7	4	3
Cash Flow from Ops. ⓘ	5.7	0.6	-20.4	0.7	2.9	5.5	0.5	-1.3	-3	10.3	-
Debt/CF from Ops. ⓘ	2.6	16.6	-0.2	23.5	6.3	3.3	28.4	-29.4	-10.5	3.4	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	7.6%	9.6%	-1.3%	19.2%
Adj EPS ⓘ	7%	-10.8%	-18.3%	-16.2%
BVPSⓘ	9.1%	4.4%	2.9%	2.9%
Share Price	11.6%	26.9%	44.9%	46%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	3.5	12.7	9.2	7.8	6.5	6.8	6.1	3.5	3.8	2.9	2.4
Op. Profit Mgn % ⓘ	0.4	2.4	2.2	2.2	1.1	1.3	2.3	2	1.6	0.6	-0.5
Net Profit Mgn % ⓘ	0.5	1.4	1.7	1.8	1.9	1.9	1.3	1	1.2	0.8	0.9
Debt to Equity ⓘ	0.4	0.2	0	0.2	0.2	0.2	0.1	0.3	0.2	0.3	-
Working Cap Days ⓘ	166	112	148	147	191	209	166	221	259	215	113
Cash Conv. Cycle ⓘ	3	6	24	63	74	54	38	58	83	65	55

Recent Performance Summary

Latest Financials

	Standalone	Consolidated
TTM EPS (₹)	1.2	-
TTM Sales (₹ Cr.)	391	-
BVPS (₹) ⓘ	51.3	-
Reserves (₹ Cr.) ⓘ	117	-
P/BV ⓘ	1.60	-
PE ⓘ	67.79	-

From the Market
52 Week Low / High (₹)	49.01 / 100.00
All Time Low / High (₹)	0.50 / 143.95
Market Cap (₹ Cr.)	233
Equity (₹ Cr.)	28.4
Face Value (₹)	10
Industry PE ⓘ	25.8

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Aarey Drugs & Pharma - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Key Ratios

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	246	396	349	355	300	348	493	419	398	474
Operating Expenses ⓘ +	245	386	341	347	297	344	481	411	391	471
Manufacturing Costs	1	0	0	2	2	5	9	8	11	10
Material Costs	242	383	337	341	290	334	466	398	375	454
Employee Cost	0	0	0	0	0	0	1	1	1	1
Other Costs ⓘ	2	3	3	3	5	4	6	5	4	6
Operating Profit ⓘ	1	10	8	8	3	5	11	8	6	3
Operating Profit Margin (%)	0.4%	2.4%	2.2%	2.2%	1.1%	1.3%	2.3%	1.8%	1.6%	0.6%
Other Income ⓘ +	3	3	3	4	7	7	3	3	5	10
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Interest ⓘ	2	4	2	2	2	2	2	3	4	5
Depreciation ⓘ	1	1	1	1	1	1	2	2	2	2
Profit Before Tax ⓘ	2	8	8	9	7	8	10	6	5	6
Tax ⓘ	1	3	2	2	1	2	3	2	1	2
Profit After Tax	1	5	6	7	6	7	7	4	5	4
PAT Margin (%)	0.5%	1.4%	1.8%	1.8%	1.9%	1.9%	1.3%	0.9%	1.2%	0.9%
Adjusted EPS (₹)	0.8	3.0	2.6	2.8	2.5	2.8	2.6	1.5	1.7	1.4
Dividend Payout Ratio (%)	0%	0%	0%	4%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	37	48	78	84	90	97	111	115	130	136
Share Capital ⓘ	17	18	23	23	23	23	25	25	28	28
Reserves ⓘ	20	30	55	61	67	73	86	90	102	108
Debt +	15	10	3	16	18	18	14	38	31	35
Long Term Debt	0	0	0	0	0	0	3	4	3	2
Short Term Debt	14	10	3	16	18	18	11	33	28	33
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	72	75	78	37	78	110	110	127	129	103
Others Liabilities ⓘ	2	9	11	8	8	8	10	11	13	17
Total Liabilities ⓘ	125	142	170	146	194	233	245	291	303	291
Fixed Assets
Net Fixed Assets ⓘ +	8	12	12	12	12	14	14	14	13	16
Gross Block	19	24	25	26	27	30	32	33	34	40
Accumulated Depreciation	11	12	13	14	15	16	18	19	21	24
CWIP ⓘ	0	0	0	0	0	0	0	0	0	0
Investments ⓘ	0	0	0	0	0	0	0	0	1	2
Inventories	2	5	15	21	17	18	14	29	35	45
Trade Receivables	72	82	95	106	96	162	136	190	184	133
Cash Equivalents	2	1	3	0	1	1	0	1	2	1
Others Assets ⓘ	41	42	44	6	68	37	80	58	68	92
Total Assets ⓘ	125	142	170	146	194	233	245	291	303	291

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	6	1	-20	1	3	5	0	-1	-3	10
PBT ⓘ	2	8	8	9	7	8	10	6	5	6
Adjustment ⓘ	2	5	3	3	3	3	4	4	5	7
Changes in Working Capital ⓘ	1	-10	-29	-9	-6	-5	-10	-9	-12	-1
Tax Paid ⓘ	0	-2	-3	-2	-2	-2	-4	-2	-1	-2
Cash Flow From Investing Activity ⓘ +	-3	-5	-1	-1	-1	-3	-3	0	-2	-6
Capex	-3	-5	-1	-1	-1	-3	-2	-1	-1	-5
Net Investments	0	-0	0	0	0	0	-1	1	-1	-1
Others ⓘ	0	-0	0	0	0	0	0	0	0	0
Cash Flow From Financing Activity ⓘ +	-2	4	23	-2	-2	-2	2	1	6	-4
Net Proceeds from Shares ⓘ	0	7	24	0	0	0	8	0	11	2
Net Proceeds from Borrowing ⓘ	0	-0	0	0	0	0	-4	4	-1	-2
Interest Paid ⓘ	-2	-4	-2	-2	-2	-2	-2	-3	-4	-5
Dividend Paid ⓘ	0	0	0	-0	0	0	0	0	0	0
Others ⓘ	0	1	2	-0	-0	-0	0	-0	1	0
Net Cash Flow ⓘ	1	-1	2	-3	0	0	-0	1	1	-0

Finance Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	3.58	12.9	9.8	8.07	6.65	6.98	6.31	3.33	3.82	3.02
ROCE (%)	7.23	22.21	14.14	12.05	8.48	9.46	9.87	6.28	6.09	6.38
Asset Turnover Ratio	2.05	2.96	2.24	2.25	1.77	1.63	2.06	1.56	1.34	1.6
PAT to CFO Conversion(x)	6	0.2	-3.33	0.14	0.5	0.71	0	-0.25	-0.6	2.5
Working Capital Days
Receivable Days	103	71	93	103	123	135	110	142	172	122
Inventory Days	5	3	10	19	23	19	12	19	29	31
Payable Days	105	70	82	61	72	103	86	109	125	93

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Aarey Drugs & Pharmaceuticals Ltd FAQs

The current trading price of Aarey Drugs & Pharma on 17-Apr-2026 16:59 is ₹82.15.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 16-Apr-2026 the market cap of Aarey Drugs & Pharma stood at ₹232.9 Cr

The latest P/E ratio of Aarey Drugs & Pharma as of 16-Apr-2026 is 67.79.

The latest P/B ratio of Aarey Drugs & Pharma as of 16-Apr-2026 is 1.60.

The 52-week high of Aarey Drugs & Pharma is ₹100.0 and the 52-week low is ₹49.01.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Aarey Drugs & Pharma is ₹391 ( Cr.) .

About Aarey Drugs & Pharmaceuticals Ltd

Aarey Drugs & Pharmaceuticals Ltd. was established in 1990. The company is engaged in the manufacturing of drugs and intermediates such as metronidazole, metronidazole benzoate, methyl, and nitro imidazole. The company is based in Thane, India.

The company also export its products to various other countries like Germany, Sri Lanka, Pakistan, Nepal and a number of African countries and is looking to establish its trade relations in other parts of the world as well.

Product range of the company includes: API/Intermediate

Metronidazol
Metronidazole Benzoate
2 Methyl -5-Nitro Imidazole

Drug deliveryPharmaceuticals / Therapeutics

Therapeutic targets of the company's products are:

Allergy
Dermatology
Infectious Diseases

Recent development

Aarey Drugs & Pharmaceuticals has recently informed that Atul A Zatakia has resigned from the Company as a Director with effect from March 01, 2009.

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

Build a Stress-Tested Portfolio.

Our Sapphire Advisory uses the ABC Concept to ensure you never have to panic during a market correction.

Core Stocks

STABILITY

Booster Stocks

GROWTH

Amplifier Stocks

ASYMMETRY

● Conflict-Free ● SEBI Registered ● 15Y+ Track Record

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Aarey Drugs & Pharmaceuticals Ltd (AAREYDRUGS) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Aarey Drugs & Pharma Share Price